Last reviewed · How we verify

NCT04360525

Different Clinicopathological Features of Non-Elderly Sigmoid Volvulus Patients

Completed Last updated 24 April 2020
What this trial tests

trial testing Reasons in Pathology in 134 participants. Completed in 18 April 2020.

Timeline
1 January 2020
Primary endpoint
1 April 2020
18 April 2020

Quick facts

Lead sponsorDr. Ersin Arslan Education and Training Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment134
Start date1 January 2020
Primary completion1 April 2020
Estimated completion18 April 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Dr. Ersin Arslan Education and Training Hospital

Who can join

Eligibility, any sex, with Pathology. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sigmoid volvulus is frequently seen in male patients over 60 years old. In the sigmoid volvulus \<60 age groups, the male/female ratio is close to each other. If sigmoid volvulus develops in \<60 age groups, it is more likely to be another underlying organic pathology.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pathology

Currently open trials in the same condition.

Other Dr. Ersin Arslan Education and Training Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04360525.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing